Microbix Biosystms (MBX) Price & Analysis

Compare

34 Followers

MBX Stock Chart & Stats

Day’s Range― - ―

52-Week RangeC$0.28 - C$0.55

Previous CloseN/A

Volume37.35K

Average Volume (3M)65.75K

Market Cap

C$42.17M

Enterprise ValueC$31.57M

Total Cash (Recent Filing)C$14.54M

Total Debt (Recent Filing)C$5.35M

Price to Earnings (P/E)25.9

Beta-0.28

Next Earnings

Aug 13, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding140,561,450

10 Day Avg. Volume57,937

30 Day Avg. Volume65,750

Financial Highlights & Ratios

PEG Ratio-1.39

Price to Book (P/B)1.33

Price to Sales (P/S)0.00

P/FCF Ratio18.44

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

C$0.50

Price Target Upside66.67% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Microbix Biosystms News

PremiumCompany Announcements

Microbix Partners with Bulgaria’s NCIPD to Enhance Diagnostic Test Accuracy

16d ago

PremiumCompany Announcements

Microbix Showcases Diagnostic Innovations at Asia Pacific Conference

1M ago

PremiumRatings

Buy Rating for Microbix Biosystems: Strong Antigen Revenue Growth and Mid-Term Market Potential

2M ago

PremiumCompany Announcements

Microbix Biosystems’ Earnings Call Highlights Growth Amid Challenges

2M ago

MBX

PremiumCompany Announcements

Microbix Biosystems Reports Q2 Fiscal 2025 Results with Improved Margins and Cautious Outlook

2M ago

PremiumCompany Announcements

Microbix and Aurevia Launch Pilot EQA Program for Bacterial Vaginosis Diagnosis

2M ago

PremiumCompany Announcements

Microbix Biosystems to Release Q2 Fiscal 2025 Results

3M ago

PremiumCompany Announcements

Microbix Advances Kinlytic Urokinase Production with New CDMO Agreement

3M ago

See All TSE:MBX News

See All News >

Bulls Say, Bears Say

Bulls Say

Market ExpansionThe increased adoption in emerging markets and expansion into recombinant antigens suggest continued robust growth.

Revenue GrowthAntigen revenues increased 118% year over year to $4.3 million, indicating strong product performance.

Trade BenefitsMicrobix products are exempt from tariffs under the USMCA trade agreement, enabling cost-effective sales into the U.S.

Bears Say

Market DemandThe unusually light burden of respiratory infectious diseases in China has decreased the demand for Microbix's antigen shipments.

Revenue DeclineTotal revenues declined 28% year over year, presenting a challenging financial performance.

Sales ImpactSales of antigens for Chinese customers have abruptly stopped, impacting a significant portion of the company's revenue.

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

15.59% Insiders

―

Mutual Funds

― Other Institutional Investors

84.41% Public Companies and

Individual Investors

Detailed Ownership Overview >

MBX FAQ

What was Microbix Biosystms J’s price range in the past 12 months?

Microbix Biosystms J lowest stock price was C$0.28 and its highest was C$0.55 in the past 12 months.

What is Microbix Biosystms J’s market cap?

Microbix Biosystms J’s market cap is C$42.17M.

When is Microbix Biosystms J’s upcoming earnings report date?

Microbix Biosystms J’s upcoming earnings report date is Aug 13, 2025 which is in 20 days.

How were Microbix Biosystms J’s earnings last quarter?

Microbix Biosystms J released its earnings results on May 15, 2025. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.

Is Microbix Biosystms J overvalued?

According to Wall Street analysts Microbix Biosystms J’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Microbix Biosystms J pay dividends?

Microbix Biosystms J does not currently pay dividends.

What is Microbix Biosystms J’s EPS estimate?

Microbix Biosystms J’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Microbix Biosystms J have?

Microbix Biosystms J has 140,561,450 shares outstanding.

What happened to Microbix Biosystms J’s price movement after its last earnings report?

Microbix Biosystms J reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -5.556%.

Which hedge fund is a major shareholder of Microbix Biosystms J?

Currently, no hedge funds are holding shares in TSE:MBX

Microbix Biosystms Stock Smart Score

Neutral

Fundamentals

Return on Equity

5.32%

Trailing 12-Months

Asset Growth

3.83%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Microbix Biosystms J

Microbix Biosystems Inc. (MBX) is a Canadian biotechnology company that specializes in the development, manufacturing, and commercialization of biological products and technologies. The company operates in sectors such as diagnostics, biopharmaceuticals, and virology, focusing on products that enhance clinical outcomes in healthcare settings. Core offerings include quality assessment products for diagnostics, antigens for immunoassays, and viral transport media.

MBX Stock 12 Month Forecast

Average Price Target

C$0.50

▲(66.67%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"C$0","1":"C$1","-1":"-C$1","-0.5":"-C$0.5","0.5":"C$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$0.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$0.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$0.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2024","6":"Aug<br/>2024","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.3,0.3153846153846154,0.33076923076923076,0.34615384615384615,0.36153846153846153,0.3769230769230769,0.3923076923076923,0.4076923076923077,0.4230769230769231,0.43846153846153846,0.45384615384615384,0.46923076923076923,0.4846153846153846,{"y":0.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.3,0.3153846153846154,0.33076923076923076,0.34615384615384615,0.36153846153846153,0.3769230769230769,0.3923076923076923,0.4076923076923077,0.4230769230769231,0.43846153846153846,0.45384615384615384,0.46923076923076923,0.4846153846153846,{"y":0.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.3,0.3153846153846154,0.33076923076923076,0.34615384615384615,0.36153846153846153,0.3769230769230769,0.3923076923076923,0.4076923076923077,0.4230769230769231,0.43846153846153846,0.45384615384615384,0.46923076923076923,0.4846153846153846,{"y":0.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.59,"date":1588291200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.59,"date":1588291200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.59,"date":1590969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.39,"date":1704067200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.38,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.34,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.34,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.3,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.49,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.42,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.36,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.33,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.3,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >